14 December 2016 EMA/68246/2017 Procedure Management and Committees Support

List of nationally authorised medicinal products

Active substance: cyproterone/ethinylestradiol

Procedure no.:

EMEA/H/N/PSR/J/0003 EMEA/H/N/PSR/J/0005 EMEA/H/N/PSR/J/0006

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

Authorisation Number of product in the member state 1-18338

MAH of product in the member state

Diane Mite

MRP/DCP Authorisation number N/A

Bayer Austria GmbH

Member State where product is authorised Austria

Minerva

N/A

1-21646

Bayer Austria GmbH

Austria

Diane-35

N/A

BE114572

Bayer SA NV, Belgium

Belgium

Diane 35

N/A

20000493

Bayer Pharma AG, Germany

Bulgaria

Diane-35 coated tablets

N/A

HR-H-931753518

Bayer doo, Croatia

Croatia

Diane-35

N/A

17/154/84-C

Bayer Pharma AG, Germany

Czech Republic

Minerva

N/A

17/173/02-C

Bayer Pharma AG, Germany

Czech Republic

Diane Mite

N/A

12301

Bayer Pharma AG, Germany

Denmark

Diane

N/A

269299

Bayer Pharma AG, Germany

Estonia

Diane Nova

N/A

9376

Bayer Oy, Finland

Finland

Diane 35

N/A

NL 14337

Bayer HealthCare, France

France

Minerva 35

N/A

NL 21987

Bayer HealthCare, France

France

Diane-35

N/A

347.01.00

Jenapharm GmbH & Co KG, Germany

Germany

Gynofen 35

N/A

39943/16-9-2009

Bayer Hellas SA, Greece

Greece

Diane

N/A

OGYI-T-1499/01 OGYI-T-1499/02

Bayer Pharma AG, Germany

Hungary

Minerva

N/A

OGYI-T-8687/01 OGYI-T-8687/02

Bayer Pharma AG, Germany

Hungary

Diane mite

N/A

MTnr. 860163(IS)

Bayer Pharma AG, Germany

Iceland

Dianette

N/A

PA 1410/003/001

Bayer Ltd, Ireland

Ireland

Diane

N/A

023777030

Bayer SpA, Italy

Italy

Diane

N/A

94-0169

Bayer Pharma AG, Germany

Latvia

Diane

N/A

LT/1/94/0413/001

Bayer Pharma AG, Germany

Lithuania

Diane-35

N/A

1987110963

Bayer SA NV, Belgium

Luxembourg

Diane-35

N/A

RVG 11903

Bayer BV, Netherlands

Netherlands

Diane

N/A

6611

Bayer Pharma AG, Germany

Norway

Diane-35

N/A

R/2222

Bayer Pharma AG, Germany

Poland

Diane 35

N/A

8507020 8507038

Berlifarma Especialidades Farmaceuticas Lda, Portugal

Portugal

Diane-35 0,035mg/2,0 mg drajeuri

N/A

5995/2013/01

Bayer Pharma AG, Germany

Romania

Minerva

N/A

17/0135/04-S

Bayer Pharma AG, Germany

Slovakia

Diane-35

N/A

17/0154/84-C/S

Bayer Pharma AG, Germany

Slovakia

Page 2/5

Product Name (in authorisation country)

Authorisation Number of product in the member state 5363-I-1489/13

MAH of product in the member state

Diane

MRP/DCP Authorisation number N/A

Bayer Pharma AG, Germany

Member State where product is authorised Slovenia

Diane 35

N/A

55.698

Bayer Hispania SL, Spain

Spain

Diane

N/A

14800

Bayer Pharma AG, Germany

Sweden

Dianette tablets

N/A

PL 00010/0526

Bayer Plc, United Kingdom

United Kingdom Poland

Cyprest

N/A

12302

Pabianickie Zakłady Farmaceutyczne Polfa S.A.

Cypromix coated tablets

N/A

OGYI-T: 20128/01-02

Aramis Pharma Kft

Hungary

Jennifer 35 2 mg/0,035 mg Filmtabletten

N/A

59938.00.00

Aristo Pharma GmbH

Germany

Co-cyprindiol 2000/35 Tablets

N/A

Cipla EU Ltd,

United Kingdom

Cyproderm

N/A

84200.00.00

Dermapharm AG

Germany

Cyprodiol

N/A

20903

SUN-FARM Sp. z o.o.

Poland

Alisma 2mg/35µg Filmtabletten

N/A

1-29268

Drehm Pharma GmbH / Gynial GmbH

Austria

Visofid

N/A

035368012

Fidia Farmaceutici S.p.A

Italy

Ciproterona + Etinilestradiol Generis

N/A

5078480 5078589

Generis Farmacêutica S.A.

Portugal

Vreya

NL/H/0623/001

17/088/06-C

Heaton k.s.

Czech republic

Vreya

NL/H/0623/001

17/0123/06-S

Heaton k.s.

Slovakia

CLAUDIA-35, 2mg/0,035mg omhulde tabletten

N/A

BE265255 BE265264

Sandoz N.V

Belgium

Feminil mite

N/A

33578

Sandoz A/S

Denmark

Feminil 2 mg/35 mikrog tabletti, päällystetty

N/A

20814

Sandoz A/S

Finland

Bella® HEXAL® 35 2mg/0,035mg überzogene Tabletten

N/A

59718.00.00

Hexal AG

Germany

Feminil 2 mg/35 mikrogram tabletter, drasjerte

N/A

05-3301

Sandoz

Norway

Acetato de Ciproterona/Etinilestradiol Sandoz 2 mg/ 0,035 mg comprimidos recubiertos EFG

N/A

68629

Sandoz Farmaceutica

Spain

Acnocin 2000/35 Tablets

N/A

PL 04416/0465

Sandoz Ltd.

United Kingdom

Page 3/5

Product Name (in authorisation country)

MRP/DCP Authorisation number

Authorisation Number of product in the member state

MAH of product in the member state

Member State where product is authorised

Cyproterone Acetate 2.00 mg Ethinylestradiol 0.035 mg Coated Tablets

N/A

PL 04416/1040

Hexal AG

United Kingdom

Daphne

N/A

BE263751

Mithra Pharmaceuticals N.V

Belgium

Ergalea 2,00/0,035 mg Filmtabletten

N/A

59939.00.00

Mithra Pharmaceuticals GmbH

Germany

Daphne

N/A

Mithra Pharmaceuticals

Luxembourg

ElisaMylan 35, 2mg/0,035 mg

N/A

BE239181

Mylan

Belgium

Evepar 2mg/0.035mg, comprimé enrobé

N/A

NL 21995

Mylan

France

Juliette

N/A

45792.00.00

Mylan

Germany

Acetato de Ciproterona/Etinilestradiol 2 mg/0.035 mg, comprimidos

N/A

2994085 2994184 2994283 2994382 2994481 2994580 2994689 2994788 2994887 2994986 2995082 2995181

Mylan

Portugal

Cyproterone Acetate/Ethinylestradiol Tablets 2 mg/0.035 mg

N/A

PL 04569/0306

Mylan

United Kingdom

Midane-Dragees

N/A

1-25324

Pelpharma Handels GmbH

Austria

Bellgyn "ratiopharm" 2mg/0,035mg überzogene Tabletten

N/A

1-25318

ratiopharm Arzneimittel Vertriebs-GmbH,

Austria

BELLUNE 35 obložene tablete

N/A

UP-I-530-09/1102/639

Pliva Hrvatska d.o.o.,

Croatia

Cypretyl

N/A

36594

Teva Denmark A/S

Denmark

CYPROTERONE/ETHINYLESTRADIOL TEVA 2 mg/0,035 mg, comprimé enrobé

N/A

34009 378 844 8 8 34009 378 845 4 9

Teva Santé,

France

Page 4/5

Product Name (in authorisation country)

MRP/DCP Authorisation number

Authorisation Number of product in the member state

MAH of product in the member state

Member State where product is authorised

Attempta-ratiopharm® 35 2 mg/0,035 mg überzogene Tablette

N/A

60439.00.00

ratiopharm GmbH, Germany

Germany

Cypretil

N/A

646709

ratiopharm GmbH, Germany

Estonia

Cypretyl

N/A

24542

ratiopharm GmbH, Germany

Finland

Cypretyl húðuð tafla

N/A

IS/1/12/094/01

ratiopharm GmbH, Germany

Iceland

Cyproteronacetaat /Ethinylestradiol 2/0,035 PCH, omhulde tabletten 2 mg/0,035 mg

N/A

RVG 33581

Pharmachemie B.V.,

Netherlands

Co-cyprindiol 2000/35 Coated Tablets

N/A

PL 00289/1604

Teva UK Limited, United Kingdom

United Kingdom

Vreya

NL/H/0623/001

38427

Stragen Nordic A/S

Denmark

Vreya 0.035 mg/2 mg

NL/H/0623/001

21514

Stragen Nordic A/S

Finland

Ethinylestradiol 0.035mg/cyproteronacetaat 2mg

NL/H/0623/001

RVG 29728

Stragen Nordic A/S

Netherlands

Clairette 2000/35

N/A

PL 21844/0009

Stragen UK Ltd

United Kingdom

Co-cyprindiol 2000/35 Coated Tablets

N/A

15764/0011

Strandhaven Limited

United Kingdom

Morea sanol 2 mg/0,035 mg überzogene Tabletten

N/A

64006.00.00

UCB Innere Medizin GmbH & Co. KG

Germany

Page 5/5

cyproterone acetate /ethinylestradiol - European Medicines Agency

Procedure Management and Committees Support. List of nationally authorised medicinal .... PL 00289/1604. Teva UK Limited, United Kingdom. United Kingdom.

124KB Sizes 23 Downloads 253 Views

Recommend Documents

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

cyproterone acetate /ethinylestradiol: CMDh scientific conclusions and ...
PASS to evaluate the effectiveness of the risk minimisation activities as imposed during ... Grounds for the variation to the terms of the Marketing Authorisation(s).

cyproterone acetate /ethinylestradiol: CMDh scientific conclusions and ...
The joint database drug utilisation final study report submitted by the MAHs, together with the ... The MAH(s) should provide within the risk management plan.

List of Cyproterone-acetate, ethinylestradiol-containing medicinal
CYPROPHARM 2 mg/0,035 mg. Laboratoires Majorelle. France. CYPROTERONE/ETHINYLESTRADIOL DCI PHARMA 2 mg/0,035 mg. DCI Pharma. France.

drospirenone / ethinylestradiol - European Medicines Agency - Europa ...
May 5, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... List of nationally authorised medicinal products.

Notice - European Medicines Agency
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti

Report - European Medicines Agency
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.

Human Medicines Highlights Newsletter - European Medicines Agency
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. • Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. • Feraccru (ferr

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...

Human Medicines Highlights Newsletter - European Medicines Agency
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...

Agenda - European Medicines Agency - europa.eu
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...

Finasteride - European Medicines Agency - europa.eu
Apr 25, 2018 - Page 2/8. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the.

Agenda - European Medicines Agency - europa.eu
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. •. Scanning the horizon for 2016 – 2018. Peter Arlett, EMA.

Human medicines highlights newsletter - European Medicines Agency
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. • Workshop on identifying opportunities for 'big data' in medicines development and ...

Human Medicines Highlights Newsletter - European Medicines Agency
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.

Agenda - European Medicines Agency veterinary medicines ...
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.

Veterinary medicines highlights 2016 - European Medicines Agency
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...

Human Medicines Highlights Newsletter - European Medicines Agency
Implant used to help new bone develop in patients with spinal disc problems and leg fractures .... E-mail [email protected] Website www.ema.europa.eu.

Human Medicines Highlights Newsletter - European Medicines Agency
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...

Registration form - European Medicines Agency
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc.

Agenda - European Medicines Agency - europa.eu
Jun 18, 2018 - 27. 7.8.1. List of all applications submitted/expected and the COMP coordinatorship distribution of .... 5,10-dihydrodibenzo[b,e][1,4] diazepin-11-one, EMA/OD/031/10 Glutathione-pegylated ...... Abbreviations / Acronyms.

Committee_Meeting dates_2017 - European Medicines Agency
Sep 26, 2016 - An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website ...